Biosynex SA (FR:ALBIO)
:ALBIO
France Market
Advertisement

Biosynex SA (ALBIO) Income Statement

Compare
2 Followers

Biosynex SA Income Statement

Last quarter (Q4 2024), Biosynex SA's total revenue was €47.50M, a decrease of -12.59% from the same quarter last year. In Q4, Biosynex SA's net income was €-22.30M. See Biosynex SA’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
€ 101.20M€ 92.98M€ 196.59M€ 382.53M€ 153.90M
Gross Profit
€ -20.00M€ 49.13M€ 64.52M€ 182.55M€ 48.10M
Operating Expenses
€ 93.75M€ 86.54M€ 63.44M€ 65.76M€ 23.58M
Depreciation and Amortization
€ 5.37M€ 24.62M€ 16.37M€ 6.61M€ 6.64M
EBITDA
€ -17.83M€ -10.18M€ 46.73M€ 146.60M€ 51.30M
Operating Income
€ -21.10M€ -37.40M€ 38.86M€ 140.65M€ 45.73M
Other Income/Expenses
€ -17.17M€ -2.27M€ -14.70M€ -3.71M€ -2.21M
Pretax Income
€ -38.43M€ -39.68M€ 24.18M€ 136.94M€ 43.52M
Net Income
€ -43.30M€ -36.95M€ 15.66M€ 104.00M€ 31.37M
Per Share Metrics
Basic EPS
€ -3.32€ -2.85€ 1.26€ 8.32€ 3.43
Diluted EPS
€ -3.32€ -2.85€ 1.26€ 8.27€ 3.05
Weighted Average Shares Outstanding
13.03M 12.97M 10.25M 10.32M 9.15M
Weighted Average Shares Outstanding (Diluted)
13.03M 12.97M 10.27M 10.39M 10.30M
Currency in EUR

Biosynex SA Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis